203 related articles for article (PubMed ID: 7705663)
1. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.
Donehower LA; Godley LA; Aldaz CM; Pyle R; Shi YP; Pinkel D; Gray J; Bradley A; Medina D; Varmus HE
Genes Dev; 1995 Apr; 9(7):882-95. PubMed ID: 7705663
[TBL] [Abstract][Full Text] [Related]
2. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis.
Gunther EJ; Moody SE; Belka GK; Hahn KT; Innocent N; Dugan KD; Cardiff RD; Chodosh LA
Genes Dev; 2003 Feb; 17(4):488-501. PubMed ID: 12600942
[TBL] [Abstract][Full Text] [Related]
3. The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model.
Donehower LA; Godley LA; Aldaz CM; Pyle R; Shi YP; Pinkel D; Gray J; Bradley A; Medina D; Varmus HE
Prog Clin Biol Res; 1996; 395():1-11. PubMed ID: 8895979
[No Abstract] [Full Text] [Related]
4. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.
Cui XS; Donehower LA
Oncogene; 2000 Dec; 19(52):5988-96. PubMed ID: 11146550
[TBL] [Abstract][Full Text] [Related]
5. Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice.
Kwan H; Pecenka V; Tsukamoto A; Parslow TG; Guzman R; Lin TP; Muller WJ; Lee FS; Leder P; Varmus HE
Mol Cell Biol; 1992 Jan; 12(1):147-54. PubMed ID: 1530875
[TBL] [Abstract][Full Text] [Related]
6. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.
Shackleford GM; MacArthur CA; Kwan HC; Varmus HE
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):740-4. PubMed ID: 8380647
[TBL] [Abstract][Full Text] [Related]
7. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2268-72. PubMed ID: 7892260
[TBL] [Abstract][Full Text] [Related]
8. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM; Shackleford GM
Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
[TBL] [Abstract][Full Text] [Related]
9. Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis.
MacArthur CA; Shankar DB; Shackleford GM
J Virol; 1995 Apr; 69(4):2501-7. PubMed ID: 7884899
[TBL] [Abstract][Full Text] [Related]
10. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
[TBL] [Abstract][Full Text] [Related]
11. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
12. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer.
Li Y; Hively WP; Varmus HE
Oncogene; 2000 Feb; 19(8):1002-9. PubMed ID: 10713683
[TBL] [Abstract][Full Text] [Related]
13. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
14. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation.
Howe LR; Watanabe O; Leonard J; Brown AM
Cancer Res; 2003 Apr; 63(8):1906-13. PubMed ID: 12702582
[TBL] [Abstract][Full Text] [Related]
15. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation.
Broccoli D; Godley LA; Donehower LA; Varmus HE; de Lange T
Mol Cell Biol; 1996 Jul; 16(7):3765-72. PubMed ID: 8668193
[TBL] [Abstract][Full Text] [Related]
17. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
Schroeder JA; Troyer KL; Lee DC
Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
19. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
[TBL] [Abstract][Full Text] [Related]
20. Hormone-induced chromosomal instability in p53-null mammary epithelium.
Pati D; Haddad BR; Haegele A; Thompson H; Kittrell FS; Shepard A; Montagna C; Zhang N; Ge G; Otta SK; McCarthy M; Ullrich RL; Medina D
Cancer Res; 2004 Aug; 64(16):5608-16. PubMed ID: 15313898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
